DXCMDexCom, Inc.
75.36USD+2.73%Mkt Cap: 29.10B USDP/E: 32.36Last update: 2026-06-01

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…

Indicators:|

Key Statistics

Company
Market Cap29.10B USD
Enterprise Value27.42B USD
Revenue (TTM)4.82B USD
Gross Profit2.80B USD
Net Income (TTM)836.30M USD
Revenue/Share12.39 USD
Last Price75.36 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS2521311074
Valuation
P/E (Trailing)32.36
P/E (Forward)24.06
PEG1.31
EV/EBITDA21.22
EV/Revenue5.69
P/S5.91
P/B9.62
EPS (TTM)2.33
EPS (Forward)3.06
52W Range
54.1159% of range89.98
52W High89.98 USD
52W Low54.11 USD
Profitability
Gross Margin60.10%
Oper. Margin21.42%
EBITDA Margin26.82%
Profit Margin17.94%
ROE30.46%
ROA13.19%
Growth
Revenue Growth15.00%
Earnings Growth92.20%
Cash Flow & Leverage
Operating CF1.44B USD
CapEx (TTM)363.50M USD
FCF Margin21.93%
FCF Yield3.63%
Net Debt-1.03B USD
Net Debt/EBITDA-0.80
Balance Sheet
Debt/Equity0.51
Current Ratio1.95
Quick Ratio1.58
Book Value/Sh7.662 USD
Cash/Share6.259 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)82.04 USD
Target Range64.00 USD112.00 USD
# Analysts25
Ownership
Shares Out.385.87M
Float384.09M
Insiders0.27%
Institutions102.56%
Short Interest
Short Ratio3.2d
Short % Float5.24%
Short % Out.4.55%
Shares Short17.56M
Short (prev mo.)15.19M
Technical
SMA 5063.79 (+18.1%)
SMA 20067.86 (+11.0%)
Beta1.40
S&P 52W Chg27.94%
Avg Vol (30d)5.93M
Avg Vol (10d)8.41M
Technical Indicators
RSI (14)68.5
MACD2.8214
MACD Signal1.5924
MACD Hist.+1.2290
BB Upper76.50 USD
BB Middle64.90 USD
BB Lower53.30 USD
BB Width35.74%
ATR (14)2.587 USD
Vol Ratio (20d)0.49x